Neurogeneticists have discovered a novel genetic mutation and associated buildup of toxic proteins in the brain -- a type of buildup distinct from amyloid or tau, proteins that have long been the ...
Enter SynPull, a new synaptosome imaging method developed by David Klenerman, John Danial, and colleagues at the University of Cambridge, England. SynPull combines single-molecule pull-down of ...
Scientists develop groundbreaking dual-action drug RI-AG03 that targets toxic tau proteins in Alzheimer's disease, showing ...
News Medical on MSN8d
Breakthrough discovery on tau protein opens new paths for Alzheimer’s drug developmentA complementary drug to combat Alzheimer's disease could target a specific part of the nerve cell protein tau. This is the finding of research from the University of Gothenburg, which also offers a ...
At the Human Amyloid Imaging (HAI) meeting, held January 15-17, researchers focused on new techniques—all based on tau and ...
The root causes of most forms of Alzheimer's disease largely remain a mystery. Now, researchers have revealed a new piece of the puzzle.
The variant causes a person's brain to accumulate beta amyloid and phosphorylated tau proteins, the hallmarks of Alzheimer's. When Whitney turned 60 and still had no symptoms, he assumed he didn't ...
A research team from the Institut de Neurociències of the Universitat Autònoma de Barcelona (INc-UAB) has discovered that the ...
Researchers from the Institut de Neurociències of the Universitat Autònoma de Barcelona (INc-UAB) have found that tau protein and beta-amyloid ... to determine whether these findings translate to ...
Scientists from Brigham and Women’s Hospital have now identified a new protein that may contribute to the disease.
“While most Alzheimer’s research has focused on the buildup of amyloid beta and tau, the polyGR proteins we’ve found ... through a patient’s entire human genome and grab a repeating ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback